Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6828)
All Articles published online
|
Publishing Process of This Article
|
Apr 21, 2020 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mori H, Suzuki H. Update on quinolone-containing rescue therapies for Helicobacter pylori infection. World J Gastroenterol 2020; 26(15): 1733-1744 [PMID: 32351290 DOI: 10.3748/wjg.v26.i15.1733] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i15/1733.htm |
| Number | Citing Articles |
| 1 |
Toshihiro Nishizawa, Kosuke Sakitani, Hidekazu Suzuki, Shuntaro Yoshida, Yosuke Kataoka, Yousuke Nakai, Hirotoshi Ebinuma, Takanori Kanai, Osamu Toyoshima, Kazuhiko Koike. Clinical features of cardiac nodularity-like appearance induced by <i>Helicobacter pylori</i> infection. World Journal of Gastroenterology 2020; 26(35): 5354-5361 doi: 10.3748/wjg.v26.i35.5354
|
| 2 |
Sooyoun Park, Eunsol Yang, Byungwook Kim, Jihoon Kwon, In‐Jin Jang, Seung Hwan Lee. Pharmacokinetic and pharmacodynamic exploration of various combinations of tegoprazan immediate and delayed‐release formulations. British Journal of Clinical Pharmacology 2023; 89(9): 2877 doi: 10.1111/bcp.15784
|
| 3 |
Hidekazu Suzuki, Hideki Mori. Single‐capsule bismuth quadruple therapy: preferable at the moment, but what should be next?. United European Gastroenterology Journal 2021; 9(1): 7 doi: 10.1177/2050640620975357
|
| 4 |
|
| 5 |
Toshihiro Nishizawa, Munkhbayar Munkjargal, Hirotoshi Ebinuma, Osamu Toyoshima, Hidekazu Suzuki. Sitafloxacin for Third-Line Helicobacter pylori Eradication: A Systematic Review. Journal of Clinical Medicine 2021; 10(12): 2722 doi: 10.3390/jcm10122722
|
| 6 |
E. A. Ortenberg, M. V. Lyapina, E. F. Dorodnyeva. Competitive proton pump inhibitors - status and Prospects of use. Experimental and Clinical Gastroenterology 2023; (4): 86 doi: 10.31146/1682-8658-ecg-212-4-86-92
|
| 7 |
Pedro Vieira de Moraes Andrade, Yan Mosca Monteiro, Ethel Zimberg Chehter. Third-line and rescue therapy for refractory <i>Helicobacter pylori</i> infection: A systematic review. World Journal of Gastroenterology 2023; 29(2): 390-409 doi: 10.3748/wjg.v29.i2.390
|
| 8 |
Youn I Choi, Sung Min Lee, Jun-Won Chung, Kyoung Oh Kim, Kwang An Kwon, Yoon Jae Kim, Jung Ho Kim, Sun Mi Lee, Jin-Yong Jeong, Dong Kyun Park. Therapeutic Potential of Sitafloxacin as a New Drug Candidate for Helicobacter Eradication in Korea: An In Vitro Culture-Based Study. Antibiotics 2021; 10(10): 1242 doi: 10.3390/antibiotics10101242
|
| 9 |
Su Young Kim, Jun-Won Chung. Best Helicobacter pylori Eradication Strategy in the Era of Antibiotic Resistance. Antibiotics 2020; 9(8): 436 doi: 10.3390/antibiotics9080436
|
| 10 |
V. T. Ivashkin, T. L. Lapina, I. V. Maev, O. M. Drapkina, R. S. Kozlov, A. A. Sheptulin, A. S. Trukhmanov, S. R. Abdulkhakov, O. P. Alekseeva, S. A. Alekseenko, D. N. Andreev, D. S. Bordin, N. N. Dekhnich, I. L. Klyaritskaya, N. V. Korochanskaya, M. F. Osipenko, E. A. Poluektova, A. S. Sarsenbaeva, V. I. Simanenkov, A. V. Tkachev, A. I. Ulyanin, I. B. Khlynov, V. V. Tsukanov. Clinical Practice Guidelines of Russian Gastroenterological Association, Scientific Society for the Clinical Study of Human Microbiome, Russian Society for the Prevention of Non-Communicable Diseases, Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy for <i>H. pylori</i> Diagnostics and Treatment in Adults. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2022; 32(6): 72 doi: 10.22416/1382-4376-2022-32-6-72-93
|
| 11 |
Soo Yeon Choi, Na Rae Lim, Woo Chul Chung. Tailored Therapy Using Bismuth Add-on Standard Triple Therapy vs. Concomitant Therapy: A First-line Regimen for Helicobacter pylori Infection. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2023; 23(2): 118 doi: 10.7704/kjhugr.2022.0058
|
| 12 |
Vincenzo De Francesco, Angelo Zullo, Raffaele Manta, Luigi Gatta, Giulia Fiorini, Ilaria M. Saracino, Dino Vaira. Helicobacter pylori eradication following first-line treatment failure in Europe: What, how and when chose among different standard regimens? A systematic review. European Journal of Gastroenterology & Hepatology 2021; 33(1S): e66 doi: 10.1097/MEG.0000000000002100
|
| 13 |
Peter Malfertheiner, Francis Megraud, Theodore Rokkas, Javier P Gisbert, Jyh-Ming Liou, Christian Schulz, Antonio Gasbarrini, Richard H Hunt, Marcis Leja, Colm O'Morain, Massimo Rugge, Sebastian Suerbaum, Herbert Tilg, Kentaro Sugano, Emad M El-Omar. Management ofHelicobacter pyloriinfection: the Maastricht VI/Florence consensus report. Gut 2022; 71(9): 1724 doi: 10.1136/gutjnl-2022-327745
|
| 14 |
Jinnan Chen, Puheng Li, Yu Huang, Yixian Guo, Zhaohui Ding, Hong Lu. Primary Antibiotic Resistance of Helicobacter pylori in Different Regions of China: A Systematic Review and Meta-Analysis. Pathogens 2022; 11(7): 786 doi: 10.3390/pathogens11070786
|